Natac, participada por Inveready, eleva un 70% sus ingresos en el primer semestre del año, hasta rozar los 20 millones

by Inveready Asset Management

Durante los seis primeros meses del año, Natac ha ingresado 19,6 millones de euros, lo que supone un incremento del 70% con respecto al mismo periodo del año pasado, mientras que su EBITDA ha supera...

Read more

Bio & Tech Smart Capital invierte en ADNTRO Genetics para impulsar el proyecto N-GENE, un test genético de uso profesional en medicina preventiva

by Noso Capital

Bio & Tech Smart Capital FCRE, fondo de capital riesgo de Noso Capital, lidera la ronda de inversión abierta por ADNTRO Genetics que asciende a 1 millón de euros, para impulsar la expansión de N-GE...

Read more

Inbergune Capital Partners, participada por Moira, lanza un fondo de biotecnología

by Moira Capital Partners

Inbergune ha decidido crear un fondo enfocado en biotecnología, dos años después de que el 60% de la empresa fuera adquirida por Moira Capital, dirigida por Javier Loizaga. Este nuevo fondo, llamad...

Read more

Fecundis secures $2.4 million in seed funding

by Parc Científic de Barcelona (PCB)

Fecundis, a medical technology start-up specialising in reproductive health, based at the Barcelona Science Park, has announced the successful closing of its seed funding round, securing $2.4 million ...

Read more

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications

by Professional Newco

Sequentia Biotech, a #deeptech and leading bioinformatics company focused on the analysis and application of omics data, announces a €10million Series A, led by Seventure Partners, a French Venture ...

Read more

Tolerance Bio closes a $17.2 million round with the participation of Columbus and Criteria

by Columbus Venture Partners

Tolerance Bio is developing an allogeneic, or “off the shelf,” thymus induced pluripotent stem cell (iPSC)-based cell therapy platform as well as pharmacological thymus therapies to address immune...

Read more

Innovación y capital se dan cita en el ‘II Columbus Investor Day’ para impulsar el futuro de la biotecnología y la salud global

by Columbus Venture Partners

Esta cita, única en España, ha concentrado el foco de atención en torno a la inteligencia artificial (IA) aplicada a la salud debido al enorme potencial para revolucionar el diagnóstico, tratamien...

Read more

The public ecosystem of the Barcelona Science Park raises 70 million euros in 2023

by Parc Científic de Barcelona (PCB)

This 2023 has been a great year in terms of funding received by the public research institutes, centres and groups at the Barcelona Science Park, which mobilised 69.9 million euros, of which 57.1 mill...

Read more

Agomab Announces $89 Million Series D Financing, with the participation of Asabys, to Support Broad Fibrosis-focused Pipeline

by Asabys Partners

Agomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors, including Asabys Partners.

Read more

INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology

by AltamarCAM Partners

The round was led by imec.xpand with new investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and Avançsa. Existing investors Asabys Partners, Aliath Bioventures and Vsquared also participated, bri...

Read more

The Riverside Company Signs Definitive Agreement to Sell HTBA to Miura Parrners

by The Riverside Company

HTBA is a science-based global leader in the manufacturing and commercialization of citrus flavonoids and active forms of vitamin B12 for the pharmaceutical, nutraceutical, food and beverage and a...

Read more

Biointaxis hosts a webinar on how to invest in its gene therapy FRATAXAV® for Friedreich’s ataxia

by Capital Cell

Biointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream